Xingwang Xie
- Molecular Biology
- Immunology top 10%
- Epidemiology top 10%
- Oncology top 10%
- Cancer Research top 10%
- Topics
- Hepatitis B Virus Studies (8 papers)Cancer Immunotherapy and Biomarkers (7 papers)Immune Cell Function and Interaction (7 papers)
- Cited by
- HepatologyCancer ResearchImmunology
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEHepatology
- Partner nations
- China
In The Last Decade
Xingwang Xie
40 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 99
- Molecular Biology 474
- Immunology 280
- Epidemiology 279
- Oncology 267
- Cancer Research 253
Countries citing papers authored by Xingwang Xie
This map shows the geographic impact of Xingwang Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingwang Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingwang Xie more than expected).
Fields of papers citing papers by Xingwang Xie
This network shows the impact of papers produced by Xingwang Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingwang Xie. The network helps show where Xingwang Xie may publish in the future.
Co-authorship network of co-authors of Xingwang Xie
This figure shows the co-authorship network connecting the top 25 collaborators of Xingwang Xie. A scholar is included among the top collaborators of Xingwang Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingwang Xie. Xingwang Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 3 | |
| 6 | 3 | |
| 7 | 2 | |
| 8 | Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma. | 24 |
| 9 | 19 | |
| 10 | 5 | |
| 11 | 18 | |
| 12 | 25 | |
| 13 | 8 | |
| 14 | 10 | |
| 15 | 217 | |
| 16 | 16 | |
| 17 | 7 | |
| 18 | 6 | |
| 19 | 34 | |
| 20 | [Correlation between interleukin-28B genetic polymorphisms and primary hepatocellular carcinoma]. | 5 |
About Xingwang Xie
Xingwang Xie is a scholar working on Hepatology, Immunology and Oncology, having authored 42 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Hepatology (211 citations), Cancer Research (253 citations) and Immunology (280 citations). Xingwang Xie has collaborated with scholars based in China. Frequent co-authors include Hongsong Chen, Lai Wei, Ran Fei, Henghui Zhang, Xueyan Wang, Gaixia He, Jinxue Zhou, Yanhui Chen, Hui Zeng and Yaxian Kong. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.